nodes	percent_of_prediction	percent_of_DWPC	metapath
Famciclovir—CYP3A4—Vandetanib—thyroid cancer	0.0693	0.508	CbGbCtD
Famciclovir—Musculoskeletal disorder—Vandetanib—thyroid cancer	0.0513	0.0594	CcSEcCtD
Famciclovir—Lipase increased—Sorafenib—thyroid cancer	0.042	0.0487	CcSEcCtD
Famciclovir—CYP3A4—Sorafenib—thyroid cancer	0.0417	0.306	CbGbCtD
Famciclovir—CYP3A4—Doxorubicin—thyroid cancer	0.0253	0.186	CbGbCtD
Famciclovir—Leukocytoclastic vasculitis—Sorafenib—thyroid cancer	0.0252	0.0292	CcSEcCtD
Famciclovir—Fungal infection—Vandetanib—thyroid cancer	0.0237	0.0275	CcSEcCtD
Famciclovir—Nasopharyngitis—Vandetanib—thyroid cancer	0.0119	0.0138	CcSEcCtD
Famciclovir—Neutropenia—Vandetanib—thyroid cancer	0.0107	0.0124	CcSEcCtD
Famciclovir—Upper respiratory tract infection—Vandetanib—thyroid cancer	0.0107	0.0124	CcSEcCtD
Famciclovir—Stevens-Johnson syndrome—Vandetanib—thyroid cancer	0.0102	0.0118	CcSEcCtD
Famciclovir—Renal failure acute—Sorafenib—thyroid cancer	0.00971	0.0112	CcSEcCtD
Famciclovir—Hepatobiliary disease—Vandetanib—thyroid cancer	0.00969	0.0112	CcSEcCtD
Famciclovir—Sinusitis—Vandetanib—thyroid cancer	0.00961	0.0111	CcSEcCtD
Famciclovir—Erythema multiforme—Vandetanib—thyroid cancer	0.00869	0.0101	CcSEcCtD
Famciclovir—Cardiac disorder—Vandetanib—thyroid cancer	0.00853	0.00988	CcSEcCtD
Famciclovir—Abdominal pain upper—Sorafenib—thyroid cancer	0.00819	0.00948	CcSEcCtD
Famciclovir—Toxic epidermal necrolysis—Sorafenib—thyroid cancer	0.00807	0.00935	CcSEcCtD
Famciclovir—Mental disorder—Vandetanib—thyroid cancer	0.00806	0.00933	CcSEcCtD
Famciclovir—Nasopharyngitis—Sorafenib—thyroid cancer	0.00802	0.00928	CcSEcCtD
Famciclovir—Abdominal discomfort—Sorafenib—thyroid cancer	0.00743	0.0086	CcSEcCtD
Famciclovir—Neutropenia—Sorafenib—thyroid cancer	0.00725	0.00839	CcSEcCtD
Famciclovir—Stevens-Johnson syndrome—Sorafenib—thyroid cancer	0.00685	0.00793	CcSEcCtD
Famciclovir—Arthralgia—Vandetanib—thyroid cancer	0.00681	0.00789	CcSEcCtD
Famciclovir—Anxiety—Vandetanib—thyroid cancer	0.00679	0.00786	CcSEcCtD
Famciclovir—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.00677	0.00784	CcSEcCtD
Famciclovir—Jaundice—Sorafenib—thyroid cancer	0.00674	0.0078	CcSEcCtD
Famciclovir—Dry mouth—Vandetanib—thyroid cancer	0.00667	0.00772	CcSEcCtD
Famciclovir—Hepatobiliary disease—Sorafenib—thyroid cancer	0.00653	0.00757	CcSEcCtD
Famciclovir—Infection—Vandetanib—thyroid cancer	0.00649	0.00752	CcSEcCtD
Famciclovir—Nervous system disorder—Vandetanib—thyroid cancer	0.00641	0.00742	CcSEcCtD
Famciclovir—Thrombocytopenia—Vandetanib—thyroid cancer	0.0064	0.00741	CcSEcCtD
Famciclovir—Skin disorder—Vandetanib—thyroid cancer	0.00635	0.00735	CcSEcCtD
Famciclovir—Herpes zoster—Epirubicin—thyroid cancer	0.00606	0.00702	CcSEcCtD
Famciclovir—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.00595	0.00689	CcSEcCtD
Famciclovir—Fungal infection—Epirubicin—thyroid cancer	0.00591	0.00685	CcSEcCtD
Famciclovir—Insomnia—Vandetanib—thyroid cancer	0.00591	0.00684	CcSEcCtD
Famciclovir—Paraesthesia—Vandetanib—thyroid cancer	0.00587	0.00679	CcSEcCtD
Famciclovir—Erythema multiforme—Sorafenib—thyroid cancer	0.00586	0.00679	CcSEcCtD
Famciclovir—Tinnitus—Sorafenib—thyroid cancer	0.00578	0.0067	CcSEcCtD
Famciclovir—Cardiac disorder—Sorafenib—thyroid cancer	0.00576	0.00667	CcSEcCtD
Famciclovir—Dyspepsia—Vandetanib—thyroid cancer	0.00575	0.00666	CcSEcCtD
Famciclovir—Decreased appetite—Vandetanib—thyroid cancer	0.00568	0.00658	CcSEcCtD
Famciclovir—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00564	0.00653	CcSEcCtD
Famciclovir—Fatigue—Vandetanib—thyroid cancer	0.00563	0.00652	CcSEcCtD
Famciclovir—Herpes zoster—Doxorubicin—thyroid cancer	0.00561	0.0065	CcSEcCtD
Famciclovir—Rigors—Epirubicin—thyroid cancer	0.00559	0.00647	CcSEcCtD
Famciclovir—Constipation—Vandetanib—thyroid cancer	0.00559	0.00647	CcSEcCtD
Famciclovir—Fungal infection—Doxorubicin—thyroid cancer	0.00547	0.00633	CcSEcCtD
Famciclovir—Mental disorder—Sorafenib—thyroid cancer	0.00543	0.00629	CcSEcCtD
Famciclovir—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00534	0.00619	CcSEcCtD
Famciclovir—Delirium—Epirubicin—thyroid cancer	0.00531	0.00615	CcSEcCtD
Famciclovir—Jaundice cholestatic—Epirubicin—thyroid cancer	0.0052	0.00602	CcSEcCtD
Famciclovir—Rigors—Doxorubicin—thyroid cancer	0.00517	0.00599	CcSEcCtD
Famciclovir—Abdominal pain—Vandetanib—thyroid cancer	0.00516	0.00598	CcSEcCtD
Famciclovir—Body temperature increased—Vandetanib—thyroid cancer	0.00516	0.00598	CcSEcCtD
Famciclovir—Hyperbilirubinaemia—Epirubicin—thyroid cancer	0.00502	0.00581	CcSEcCtD
Famciclovir—Anaemia—Sorafenib—thyroid cancer	0.00499	0.00578	CcSEcCtD
Famciclovir—Angioedema—Sorafenib—thyroid cancer	0.00493	0.00571	CcSEcCtD
Famciclovir—Delirium—Doxorubicin—thyroid cancer	0.00491	0.00569	CcSEcCtD
Famciclovir—Leukopenia—Sorafenib—thyroid cancer	0.00483	0.0056	CcSEcCtD
Famciclovir—Jaundice cholestatic—Doxorubicin—thyroid cancer	0.00481	0.00557	CcSEcCtD
Famciclovir—Asthenia—Vandetanib—thyroid cancer	0.00469	0.00543	CcSEcCtD
Famciclovir—Hyperbilirubinaemia—Doxorubicin—thyroid cancer	0.00464	0.00538	CcSEcCtD
Famciclovir—Pruritus—Vandetanib—thyroid cancer	0.00462	0.00535	CcSEcCtD
Famciclovir—Myalgia—Sorafenib—thyroid cancer	0.0046	0.00532	CcSEcCtD
Famciclovir—Arthralgia—Sorafenib—thyroid cancer	0.0046	0.00532	CcSEcCtD
Famciclovir—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00457	0.00529	CcSEcCtD
Famciclovir—Dry mouth—Sorafenib—thyroid cancer	0.0045	0.00521	CcSEcCtD
Famciclovir—Diarrhoea—Vandetanib—thyroid cancer	0.00447	0.00518	CcSEcCtD
Famciclovir—Infection—Sorafenib—thyroid cancer	0.00438	0.00507	CcSEcCtD
Famciclovir—Nervous system disorder—Sorafenib—thyroid cancer	0.00432	0.005	CcSEcCtD
Famciclovir—Dizziness—Vandetanib—thyroid cancer	0.00432	0.005	CcSEcCtD
Famciclovir—Thrombocytopenia—Sorafenib—thyroid cancer	0.00431	0.005	CcSEcCtD
Famciclovir—Skin disorder—Sorafenib—thyroid cancer	0.00428	0.00496	CcSEcCtD
Famciclovir—Anorexia—Sorafenib—thyroid cancer	0.0042	0.00486	CcSEcCtD
Famciclovir—Vomiting—Vandetanib—thyroid cancer	0.00415	0.00481	CcSEcCtD
Famciclovir—Rash—Vandetanib—thyroid cancer	0.00412	0.00477	CcSEcCtD
Famciclovir—Dermatitis—Vandetanib—thyroid cancer	0.00412	0.00477	CcSEcCtD
Famciclovir—Headache—Vandetanib—thyroid cancer	0.00409	0.00474	CcSEcCtD
Famciclovir—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00402	0.00465	CcSEcCtD
Famciclovir—Nausea—Vandetanib—thyroid cancer	0.00388	0.00449	CcSEcCtD
Famciclovir—Dyspepsia—Sorafenib—thyroid cancer	0.00388	0.00449	CcSEcCtD
Famciclovir—Decreased appetite—Sorafenib—thyroid cancer	0.00383	0.00444	CcSEcCtD
Famciclovir—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.0038	0.00441	CcSEcCtD
Famciclovir—Fatigue—Sorafenib—thyroid cancer	0.0038	0.0044	CcSEcCtD
Famciclovir—Constipation—Sorafenib—thyroid cancer	0.00377	0.00436	CcSEcCtD
Famciclovir—Gastrointestinal pain—Sorafenib—thyroid cancer	0.0036	0.00417	CcSEcCtD
Famciclovir—Renal failure acute—Epirubicin—thyroid cancer	0.00359	0.00416	CcSEcCtD
Famciclovir—Urticaria—Sorafenib—thyroid cancer	0.0035	0.00405	CcSEcCtD
Famciclovir—Body temperature increased—Sorafenib—thyroid cancer	0.00348	0.00403	CcSEcCtD
Famciclovir—Abdominal pain—Sorafenib—thyroid cancer	0.00348	0.00403	CcSEcCtD
Famciclovir—Renal failure acute—Doxorubicin—thyroid cancer	0.00332	0.00385	CcSEcCtD
Famciclovir—Migraine—Epirubicin—thyroid cancer	0.00326	0.00378	CcSEcCtD
Famciclovir—Face oedema—Epirubicin—thyroid cancer	0.0032	0.0037	CcSEcCtD
Famciclovir—Asthenia—Sorafenib—thyroid cancer	0.00316	0.00366	CcSEcCtD
Famciclovir—Pruritus—Sorafenib—thyroid cancer	0.00312	0.00361	CcSEcCtD
Famciclovir—Liver function test abnormal—Epirubicin—thyroid cancer	0.00306	0.00354	CcSEcCtD
Famciclovir—Abdominal pain upper—Epirubicin—thyroid cancer	0.00303	0.0035	CcSEcCtD
Famciclovir—Migraine—Doxorubicin—thyroid cancer	0.00302	0.00349	CcSEcCtD
Famciclovir—Diarrhoea—Sorafenib—thyroid cancer	0.00302	0.00349	CcSEcCtD
Famciclovir—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.00298	0.00346	CcSEcCtD
Famciclovir—Nasopharyngitis—Epirubicin—thyroid cancer	0.00296	0.00343	CcSEcCtD
Famciclovir—Face oedema—Doxorubicin—thyroid cancer	0.00296	0.00343	CcSEcCtD
Famciclovir—Dizziness—Sorafenib—thyroid cancer	0.00291	0.00337	CcSEcCtD
Famciclovir—Liver function test abnormal—Doxorubicin—thyroid cancer	0.00283	0.00328	CcSEcCtD
Famciclovir—Vomiting—Sorafenib—thyroid cancer	0.0028	0.00324	CcSEcCtD
Famciclovir—Abdominal pain upper—Doxorubicin—thyroid cancer	0.0028	0.00324	CcSEcCtD
Famciclovir—Rash—Sorafenib—thyroid cancer	0.00278	0.00322	CcSEcCtD
Famciclovir—Dermatitis—Sorafenib—thyroid cancer	0.00278	0.00321	CcSEcCtD
Famciclovir—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.00276	0.0032	CcSEcCtD
Famciclovir—Headache—Sorafenib—thyroid cancer	0.00276	0.0032	CcSEcCtD
Famciclovir—Nasopharyngitis—Doxorubicin—thyroid cancer	0.00274	0.00317	CcSEcCtD
Famciclovir—Neutropenia—Epirubicin—thyroid cancer	0.00268	0.0031	CcSEcCtD
Famciclovir—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.00266	0.00308	CcSEcCtD
Famciclovir—Nausea—Sorafenib—thyroid cancer	0.00262	0.00303	CcSEcCtD
Famciclovir—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.00253	0.00293	CcSEcCtD
Famciclovir—Jaundice—Epirubicin—thyroid cancer	0.00249	0.00288	CcSEcCtD
Famciclovir—Neutropenia—Doxorubicin—thyroid cancer	0.00248	0.00287	CcSEcCtD
Famciclovir—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.00246	0.00285	CcSEcCtD
Famciclovir—Hepatobiliary disease—Epirubicin—thyroid cancer	0.00242	0.0028	CcSEcCtD
Famciclovir—Sinusitis—Epirubicin—thyroid cancer	0.0024	0.00277	CcSEcCtD
Famciclovir—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.00234	0.00271	CcSEcCtD
Famciclovir—Jaundice—Doxorubicin—thyroid cancer	0.0023	0.00267	CcSEcCtD
Famciclovir—Pharyngitis—Epirubicin—thyroid cancer	0.00228	0.00263	CcSEcCtD
Famciclovir—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.00223	0.00259	CcSEcCtD
Famciclovir—Sinusitis—Doxorubicin—thyroid cancer	0.00222	0.00257	CcSEcCtD
Famciclovir—Erythema multiforme—Epirubicin—thyroid cancer	0.00217	0.00251	CcSEcCtD
Famciclovir—Tinnitus—Epirubicin—thyroid cancer	0.00214	0.00247	CcSEcCtD
Famciclovir—Cardiac disorder—Epirubicin—thyroid cancer	0.00213	0.00246	CcSEcCtD
Famciclovir—Pharyngitis—Doxorubicin—thyroid cancer	0.00211	0.00244	CcSEcCtD
Famciclovir—Chills—Epirubicin—thyroid cancer	0.00206	0.00238	CcSEcCtD
Famciclovir—Mental disorder—Epirubicin—thyroid cancer	0.00201	0.00233	CcSEcCtD
Famciclovir—Erythema multiforme—Doxorubicin—thyroid cancer	0.00201	0.00232	CcSEcCtD
Famciclovir—Tinnitus—Doxorubicin—thyroid cancer	0.00198	0.00229	CcSEcCtD
Famciclovir—Cardiac disorder—Doxorubicin—thyroid cancer	0.00197	0.00228	CcSEcCtD
Famciclovir—Flatulence—Epirubicin—thyroid cancer	0.00197	0.00228	CcSEcCtD
Famciclovir—Back pain—Epirubicin—thyroid cancer	0.00193	0.00224	CcSEcCtD
Famciclovir—Chills—Doxorubicin—thyroid cancer	0.0019	0.0022	CcSEcCtD
Famciclovir—Mental disorder—Doxorubicin—thyroid cancer	0.00186	0.00215	CcSEcCtD
Famciclovir—Anaemia—Epirubicin—thyroid cancer	0.00184	0.00214	CcSEcCtD
Famciclovir—Flatulence—Doxorubicin—thyroid cancer	0.00182	0.00211	CcSEcCtD
Famciclovir—Leukopenia—Epirubicin—thyroid cancer	0.00179	0.00207	CcSEcCtD
Famciclovir—Back pain—Doxorubicin—thyroid cancer	0.00179	0.00207	CcSEcCtD
Famciclovir—Palpitations—Epirubicin—thyroid cancer	0.00176	0.00204	CcSEcCtD
Famciclovir—Anaemia—Doxorubicin—thyroid cancer	0.00171	0.00198	CcSEcCtD
Famciclovir—Arthralgia—Epirubicin—thyroid cancer	0.0017	0.00197	CcSEcCtD
Famciclovir—Myalgia—Epirubicin—thyroid cancer	0.0017	0.00197	CcSEcCtD
Famciclovir—Anxiety—Epirubicin—thyroid cancer	0.00169	0.00196	CcSEcCtD
Famciclovir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.00169	0.00195	CcSEcCtD
Famciclovir—Dry mouth—Epirubicin—thyroid cancer	0.00166	0.00192	CcSEcCtD
Famciclovir—Leukopenia—Doxorubicin—thyroid cancer	0.00165	0.00191	CcSEcCtD
Famciclovir—Confusional state—Epirubicin—thyroid cancer	0.00164	0.0019	CcSEcCtD
Famciclovir—Palpitations—Doxorubicin—thyroid cancer	0.00163	0.00189	CcSEcCtD
Famciclovir—Infection—Epirubicin—thyroid cancer	0.00162	0.00187	CcSEcCtD
Famciclovir—Nervous system disorder—Epirubicin—thyroid cancer	0.0016	0.00185	CcSEcCtD
Famciclovir—Thrombocytopenia—Epirubicin—thyroid cancer	0.00159	0.00185	CcSEcCtD
Famciclovir—Skin disorder—Epirubicin—thyroid cancer	0.00158	0.00183	CcSEcCtD
Famciclovir—Hyperhidrosis—Epirubicin—thyroid cancer	0.00157	0.00182	CcSEcCtD
Famciclovir—Myalgia—Doxorubicin—thyroid cancer	0.00157	0.00182	CcSEcCtD
Famciclovir—Arthralgia—Doxorubicin—thyroid cancer	0.00157	0.00182	CcSEcCtD
Famciclovir—Anxiety—Doxorubicin—thyroid cancer	0.00157	0.00181	CcSEcCtD
Famciclovir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.00156	0.00181	CcSEcCtD
Famciclovir—Anorexia—Epirubicin—thyroid cancer	0.00155	0.0018	CcSEcCtD
Famciclovir—Dry mouth—Doxorubicin—thyroid cancer	0.00154	0.00178	CcSEcCtD
Famciclovir—Confusional state—Doxorubicin—thyroid cancer	0.00152	0.00176	CcSEcCtD
Famciclovir—Infection—Doxorubicin—thyroid cancer	0.0015	0.00173	CcSEcCtD
Famciclovir—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.00148	0.00172	CcSEcCtD
Famciclovir—Nervous system disorder—Doxorubicin—thyroid cancer	0.00148	0.00171	CcSEcCtD
Famciclovir—Thrombocytopenia—Doxorubicin—thyroid cancer	0.00148	0.00171	CcSEcCtD
Famciclovir—Insomnia—Epirubicin—thyroid cancer	0.00147	0.00171	CcSEcCtD
Famciclovir—Skin disorder—Doxorubicin—thyroid cancer	0.00146	0.00169	CcSEcCtD
Famciclovir—Paraesthesia—Epirubicin—thyroid cancer	0.00146	0.00169	CcSEcCtD
Famciclovir—Hyperhidrosis—Doxorubicin—thyroid cancer	0.00146	0.00169	CcSEcCtD
Famciclovir—Somnolence—Epirubicin—thyroid cancer	0.00145	0.00168	CcSEcCtD
Famciclovir—Anorexia—Doxorubicin—thyroid cancer	0.00144	0.00166	CcSEcCtD
Famciclovir—Dyspepsia—Epirubicin—thyroid cancer	0.00143	0.00166	CcSEcCtD
Famciclovir—Decreased appetite—Epirubicin—thyroid cancer	0.00142	0.00164	CcSEcCtD
Famciclovir—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.00141	0.00163	CcSEcCtD
Famciclovir—Fatigue—Epirubicin—thyroid cancer	0.0014	0.00163	CcSEcCtD
Famciclovir—Constipation—Epirubicin—thyroid cancer	0.00139	0.00161	CcSEcCtD
Famciclovir—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.00137	0.00159	CcSEcCtD
Famciclovir—Insomnia—Doxorubicin—thyroid cancer	0.00136	0.00158	CcSEcCtD
Famciclovir—Paraesthesia—Doxorubicin—thyroid cancer	0.00135	0.00157	CcSEcCtD
Famciclovir—Feeling abnormal—Epirubicin—thyroid cancer	0.00134	0.00155	CcSEcCtD
Famciclovir—Somnolence—Doxorubicin—thyroid cancer	0.00134	0.00155	CcSEcCtD
Famciclovir—Gastrointestinal pain—Epirubicin—thyroid cancer	0.00133	0.00154	CcSEcCtD
Famciclovir—Dyspepsia—Doxorubicin—thyroid cancer	0.00133	0.00154	CcSEcCtD
Famciclovir—Decreased appetite—Doxorubicin—thyroid cancer	0.00131	0.00152	CcSEcCtD
Famciclovir—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.0013	0.00151	CcSEcCtD
Famciclovir—Fatigue—Doxorubicin—thyroid cancer	0.0013	0.0015	CcSEcCtD
Famciclovir—Urticaria—Epirubicin—thyroid cancer	0.00129	0.0015	CcSEcCtD
Famciclovir—Constipation—Doxorubicin—thyroid cancer	0.00129	0.00149	CcSEcCtD
Famciclovir—Abdominal pain—Epirubicin—thyroid cancer	0.00129	0.00149	CcSEcCtD
Famciclovir—Body temperature increased—Epirubicin—thyroid cancer	0.00129	0.00149	CcSEcCtD
Famciclovir—Feeling abnormal—Doxorubicin—thyroid cancer	0.00124	0.00144	CcSEcCtD
Famciclovir—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.00123	0.00143	CcSEcCtD
Famciclovir—Urticaria—Doxorubicin—thyroid cancer	0.0012	0.00139	CcSEcCtD
Famciclovir—Body temperature increased—Doxorubicin—thyroid cancer	0.00119	0.00138	CcSEcCtD
Famciclovir—Abdominal pain—Doxorubicin—thyroid cancer	0.00119	0.00138	CcSEcCtD
Famciclovir—Asthenia—Epirubicin—thyroid cancer	0.00117	0.00135	CcSEcCtD
Famciclovir—Pruritus—Epirubicin—thyroid cancer	0.00115	0.00133	CcSEcCtD
Famciclovir—Diarrhoea—Epirubicin—thyroid cancer	0.00111	0.00129	CcSEcCtD
Famciclovir—Asthenia—Doxorubicin—thyroid cancer	0.00108	0.00125	CcSEcCtD
Famciclovir—Dizziness—Epirubicin—thyroid cancer	0.00108	0.00125	CcSEcCtD
Famciclovir—Pruritus—Doxorubicin—thyroid cancer	0.00107	0.00123	CcSEcCtD
Famciclovir—Vomiting—Epirubicin—thyroid cancer	0.00104	0.0012	CcSEcCtD
Famciclovir—Diarrhoea—Doxorubicin—thyroid cancer	0.00103	0.00119	CcSEcCtD
Famciclovir—Rash—Epirubicin—thyroid cancer	0.00103	0.00119	CcSEcCtD
Famciclovir—Dermatitis—Epirubicin—thyroid cancer	0.00103	0.00119	CcSEcCtD
Famciclovir—Headache—Epirubicin—thyroid cancer	0.00102	0.00118	CcSEcCtD
Famciclovir—Dizziness—Doxorubicin—thyroid cancer	0.000997	0.00115	CcSEcCtD
Famciclovir—Nausea—Epirubicin—thyroid cancer	0.000967	0.00112	CcSEcCtD
Famciclovir—Vomiting—Doxorubicin—thyroid cancer	0.000958	0.00111	CcSEcCtD
Famciclovir—Rash—Doxorubicin—thyroid cancer	0.00095	0.0011	CcSEcCtD
Famciclovir—Dermatitis—Doxorubicin—thyroid cancer	0.000949	0.0011	CcSEcCtD
Famciclovir—Headache—Doxorubicin—thyroid cancer	0.000944	0.00109	CcSEcCtD
Famciclovir—Nausea—Doxorubicin—thyroid cancer	0.000895	0.00104	CcSEcCtD
